Differential Diagnosis and Prognosis of Fetuses with Bilateral Enlarged, Hyperechogenic Kidneys: Renal Volume and Amniotic Fluid Volume with Advancing Gestation.
Journal
Zeitschrift fur Geburtshilfe und Neonatologie
ISSN: 1439-1651
Titre abrégé: Z Geburtshilfe Neonatol
Pays: Germany
ID NLM: 9508901
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
pubmed:
8
9
2021
medline:
15
4
2022
entrez:
7
9
2021
Statut:
ppublish
Résumé
This study's objective was to identify prenatal criteria helping differential diagnosis of bilateral enlarged, hyperechogenic kidneys, especially looking at development of renal volume and amniotic fluid volume with increasing gestational age. Retrospective analysis (single-center database) of all bilateral enlarged, hyperechogenic kidneys between 2000-2018. Renal enlargement was defined as renal volume>90 23 cases fulfilled the inclusion criteria. 12 pregnancies were terminated. For 11 continued pregnancies, longitudinal information on amniotic fluid volume and renal volume were available. 4 cases with oligohydramnios showed a progressive reduction; 6 cases with normal/increased amniotic fluid volume remained stable; in 1 case amniotic fluid volume normalized from initially being oligohydramnios. Regarding renal volume, 4 cases showed exponential enlargement, 3 cases linear progression; in 2 cases renal volume stabilized after initial progression; 2 cases showed initial progression and secondary regression. 4 fetuses survived: 3 autosomal dominant polycystic kidney diseases, 1 Bardet-Biedl syndrome. Progressive reduction of amniotic fluid volume with exponential increase of renal volume is highly suggestive for autosomal recessive polycystic kidney disease. Cases of autosomal dominant polycystic kidney disease show a linear progression of renal volume>90
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
98-103Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest. The content of this paper was presented orally at the Annual Conference of Gynécologie Suisse (SGGG) in June 2019 in St. Gallen, Switzerland.